Navigation Links
New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
Date:3/19/2009

  • The 6 studies that are in the Sinus Dynamics Clinical study site shows that Topical treatment is effective in treatment of Sinusitis.
  • The new attached study (http://www.sinusdynamics.com/differential-deposition-of-aerosols.html) features the most proof that the Sinus Dynamics treatment has the smallest particle size, and because of this reason, the medication can be delivered deeper, while depositing more of the medication into the sinuses for better treatment of Sinusitis and Sinus Infection.
  • 82.9% success rate in treatment of sinusitis and Sinus Infection through Sinus Dynamics particle size.
Sinusitis is a chronic medical condition that can affect up to 38 million people each year. Most sinusitis and allergy suffers will become frustrated from the numerous treatments that they have used, including surgery, which may result in little to no improvement. With an 82.9% success rate, the Sinus Dynamics program has added 18 new topical medications which are combinations of Antibiotics, Anti-Fungal, and anti-inflammatory.

The Sinus Dynamics program is a unique form of treatment. Thousands of patients have at last found the relief that they have been longing for from their ongoing allergies and sinusitis infections with the Sinus Dynamics program in the five years since it has begun. Please check the testimonials on www.sinusdynamics.com.

If a sinusitis patient is tired of being disappointed by the continuous failing sinusitis
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief  through Sinus Dynamics 
(Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... 2014 Helen Harris’ RP (Retinitis Pigmentosa) ... California after an 8 year battle with breast cancer. ... evening in her home in Woodland Hills California after ... , As the founder and volunteer ... pioneered and championed many of today's greatest breakthroughs in ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... , WEDNESDAY, Feb. 1 (HealthDay News) -- Child abuse and ... is comparable to the costs of other major public health ... U.S. Centers for Disease Control and Prevention analyzed 1,740 fatal ... of one year. The investigators found that the lifetime ...
... Ore. Researchers have developed a type of wearable, non-invasive ... rate and respiration at the same time it records a ... and patient care. The device is just two inches ... with the skin and can operate for a week without ...
... , WEDNESDAY, Feb. 1 (HealthDay News) -- About one ... the United States by Pfizer Inc. because of a packaging ... cause unintended pregnancies. The recall of 14 lots of ... Estradiol tablets was announced late Tuesday after Pfizer discovered that ...
... WEDNESDAY, Feb. 1 (HealthDay News) -- Many adults whose parents ... brain aging in middle age that may precede a stroke, ... with an average age of 61 who underwent MRI brain ... the volume of white matter lesions and other signs of ...
... ) publishes online and in print today a ... form cutting-edge genomic and epigenomic analyses of cancer. ... biological insights gained from genomic analyses of pancreatic ... analyses of breast cancer genes, large scale colorectal ...
... that can cause inflammation and organ failure, has different ... why some people are very susceptible to the infection, ... they could study liver cells from different people in ... these varying responses. However, liver cells are difficult to ...
Cached Medicine News:Health News:Child Abuse, Neglect a Major Public Health Problem: CDC 2Health News:Pfizer Recalls 1 Million Packets of Birth Control Pills 2Health News:Adult Children of Stroke Sufferers May Show Signs of Brain Aging, Too 2Health News:Genome Research publishes special issue: Cancer Genomics 2Health News:Genome Research publishes special issue: Cancer Genomics 3Health News:Genome Research publishes special issue: Cancer Genomics 4Health News:Genome Research publishes special issue: Cancer Genomics 5Health News:Genome Research publishes special issue: Cancer Genomics 6Health News:Genome Research publishes special issue: Cancer Genomics 7Health News:MIT: Stem cells could drive hepatitis research forward 2Health News:MIT: Stem cells could drive hepatitis research forward 3
(Date:12/24/2014)... SCHOFIELD, Wis. , Dec. 23, 2014 ... and marketer of over-the-counter (OTC) medicinal and healthcare products, ... production of MigraPure® H, a hemp-based, advanced headache relief ... marijuana dispensaries in Colorado , ... . With the MigraPure H Advanced ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... , Dec. 23, 2014 In response to urgent ... of Sierra Leone , Direct Relief delivered ... for the treatment of local health workers who contract ... new dedicated Ebola care center was constructed for foreign health ... is not available for local Sierra Leonean health workers. ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... 2011 Over 130 organizations, community leaders, health care ... inner-cities across the country today urged Express Scripts to ... is necessary to protect access to pharmacy services for ... urge Express Scripts to put the people of our ...
... Ill., Dec. 22, 2011 AuraSense Therapeutics, ... (SNA™) constructs as gene regulation- and chemo-therapeutics ... in oncology, dermatology, neurology, and for cardiovascular ... Investors included Abbott Biotech Ventures, a subsidiary ...
Cached Medicine Technology:Over 130 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2AuraSense Therapeutics Secures Series B Equity Investment 2
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Uro San® Plus male external catheter is a latex catheter with a double-sided adhesive and Shield Skin Protective Dressing....
... Pak Seven Starter Kit: a ... of Freedom Clear catheters and ... 100% latex-free along with ... convenience and comfort. Plus each ...
Medicine Products: